Urinary Transforming Growth Factor-β-Induced Gene-h3 (βig-h3) as a Sensitive Predictor in Chronic Cyclosporine Nephrotoxicity

C. D. Kim, Y. J. Cho, S. H. Park, S. W. Ha, E. G. Lee, Y. J. Kim, T. H. Kwon, In-San Kim, Y. L. Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Transforming growth factor (TGF)-β is involved in the pathogenesis of chronic cyclosporine nephrotoxicity (CyAN). Since the expression of TGF-β induced gene h3 (βig-h3) is up-regulated by TGF-β, we evaluated the potential role of βig-h3 as a sensitive urinary marker to monitor the progression/regression of chronic CyAN. Urinary βig-h3 levels were determined using an enzyme-linked immunosorbent assay in nine patients with chronic CyAN and 13 patients with stable graft function. We scored the extent of tubulointerstitial fibrosis (TIF) and using immunoperoxidase labeling, determined βig-h3 expression in renal tissues of patients with chronic CyAN. Urinary βig-h3 excretion was higher in chronic CyAN compared to control subjects (173.4 ± 26.0 vs 62.6 ± 5.0 ng/mg creatinine, P < .01). In chronic CyAN, the degree of TIF correlated with increased urinary βig-h3 levels (r = .785, P < .05). In kidneys with chronic CyAN, βig-h3 labeling was more prominent at the basement membranes (BM) of the tubules where inflammatory cells had infiltrated the surrounding interstitium. Moreover, the BM of the atrophied tubules and their surrounding interstitium were strongly labeled. Urinary βig-h3 levels decreased from 173.4 ± 26.0 to 64.9 ± 14.4 ng/mg creatinine at 1 month after discontinuation of CyA or reduction in CyA dosage (P < .01) despite unchanged serum creatinine levels. Urinary βig-h3 levels increased in patients with chronic CyAN and decreased after discontinuation or reduction of CyA dosage. Our results suggested that urinary βig-h3 levels could be used as a sensitive urinary marker to monitor the progression or regression of chronic CyAN.

Original languageEnglish
Pages (from-to)1314-1319
Number of pages6
JournalTransplantation Proceedings
Volume38
Issue number5
DOIs
Publication statusPublished - 2006 Jun 1
Externally publishedYes

Fingerprint

Transforming Growth Factors
Cyclosporine
Genes
Creatinine
Basement Membrane
Fibrosis
Kidney
Enzyme-Linked Immunosorbent Assay
Transplants
Gene Expression
Serum

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Urinary Transforming Growth Factor-β-Induced Gene-h3 (βig-h3) as a Sensitive Predictor in Chronic Cyclosporine Nephrotoxicity. / Kim, C. D.; Cho, Y. J.; Park, S. H.; Ha, S. W.; Lee, E. G.; Kim, Y. J.; Kwon, T. H.; Kim, In-San; Kim, Y. L.

In: Transplantation Proceedings, Vol. 38, No. 5, 01.06.2006, p. 1314-1319.

Research output: Contribution to journalArticle

Kim, C. D. ; Cho, Y. J. ; Park, S. H. ; Ha, S. W. ; Lee, E. G. ; Kim, Y. J. ; Kwon, T. H. ; Kim, In-San ; Kim, Y. L. / Urinary Transforming Growth Factor-β-Induced Gene-h3 (βig-h3) as a Sensitive Predictor in Chronic Cyclosporine Nephrotoxicity. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 5. pp. 1314-1319.
@article{1d088519485f49bda49da4a0bbc2c42e,
title = "Urinary Transforming Growth Factor-β-Induced Gene-h3 (βig-h3) as a Sensitive Predictor in Chronic Cyclosporine Nephrotoxicity",
abstract = "Transforming growth factor (TGF)-β is involved in the pathogenesis of chronic cyclosporine nephrotoxicity (CyAN). Since the expression of TGF-β induced gene h3 (βig-h3) is up-regulated by TGF-β, we evaluated the potential role of βig-h3 as a sensitive urinary marker to monitor the progression/regression of chronic CyAN. Urinary βig-h3 levels were determined using an enzyme-linked immunosorbent assay in nine patients with chronic CyAN and 13 patients with stable graft function. We scored the extent of tubulointerstitial fibrosis (TIF) and using immunoperoxidase labeling, determined βig-h3 expression in renal tissues of patients with chronic CyAN. Urinary βig-h3 excretion was higher in chronic CyAN compared to control subjects (173.4 ± 26.0 vs 62.6 ± 5.0 ng/mg creatinine, P < .01). In chronic CyAN, the degree of TIF correlated with increased urinary βig-h3 levels (r = .785, P < .05). In kidneys with chronic CyAN, βig-h3 labeling was more prominent at the basement membranes (BM) of the tubules where inflammatory cells had infiltrated the surrounding interstitium. Moreover, the BM of the atrophied tubules and their surrounding interstitium were strongly labeled. Urinary βig-h3 levels decreased from 173.4 ± 26.0 to 64.9 ± 14.4 ng/mg creatinine at 1 month after discontinuation of CyA or reduction in CyA dosage (P < .01) despite unchanged serum creatinine levels. Urinary βig-h3 levels increased in patients with chronic CyAN and decreased after discontinuation or reduction of CyA dosage. Our results suggested that urinary βig-h3 levels could be used as a sensitive urinary marker to monitor the progression or regression of chronic CyAN.",
author = "Kim, {C. D.} and Cho, {Y. J.} and Park, {S. H.} and Ha, {S. W.} and Lee, {E. G.} and Kim, {Y. J.} and Kwon, {T. H.} and In-San Kim and Kim, {Y. L.}",
year = "2006",
month = "6",
day = "1",
doi = "10.1016/j.transproceed.2006.02.070",
language = "English",
volume = "38",
pages = "1314--1319",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Urinary Transforming Growth Factor-β-Induced Gene-h3 (βig-h3) as a Sensitive Predictor in Chronic Cyclosporine Nephrotoxicity

AU - Kim, C. D.

AU - Cho, Y. J.

AU - Park, S. H.

AU - Ha, S. W.

AU - Lee, E. G.

AU - Kim, Y. J.

AU - Kwon, T. H.

AU - Kim, In-San

AU - Kim, Y. L.

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Transforming growth factor (TGF)-β is involved in the pathogenesis of chronic cyclosporine nephrotoxicity (CyAN). Since the expression of TGF-β induced gene h3 (βig-h3) is up-regulated by TGF-β, we evaluated the potential role of βig-h3 as a sensitive urinary marker to monitor the progression/regression of chronic CyAN. Urinary βig-h3 levels were determined using an enzyme-linked immunosorbent assay in nine patients with chronic CyAN and 13 patients with stable graft function. We scored the extent of tubulointerstitial fibrosis (TIF) and using immunoperoxidase labeling, determined βig-h3 expression in renal tissues of patients with chronic CyAN. Urinary βig-h3 excretion was higher in chronic CyAN compared to control subjects (173.4 ± 26.0 vs 62.6 ± 5.0 ng/mg creatinine, P < .01). In chronic CyAN, the degree of TIF correlated with increased urinary βig-h3 levels (r = .785, P < .05). In kidneys with chronic CyAN, βig-h3 labeling was more prominent at the basement membranes (BM) of the tubules where inflammatory cells had infiltrated the surrounding interstitium. Moreover, the BM of the atrophied tubules and their surrounding interstitium were strongly labeled. Urinary βig-h3 levels decreased from 173.4 ± 26.0 to 64.9 ± 14.4 ng/mg creatinine at 1 month after discontinuation of CyA or reduction in CyA dosage (P < .01) despite unchanged serum creatinine levels. Urinary βig-h3 levels increased in patients with chronic CyAN and decreased after discontinuation or reduction of CyA dosage. Our results suggested that urinary βig-h3 levels could be used as a sensitive urinary marker to monitor the progression or regression of chronic CyAN.

AB - Transforming growth factor (TGF)-β is involved in the pathogenesis of chronic cyclosporine nephrotoxicity (CyAN). Since the expression of TGF-β induced gene h3 (βig-h3) is up-regulated by TGF-β, we evaluated the potential role of βig-h3 as a sensitive urinary marker to monitor the progression/regression of chronic CyAN. Urinary βig-h3 levels were determined using an enzyme-linked immunosorbent assay in nine patients with chronic CyAN and 13 patients with stable graft function. We scored the extent of tubulointerstitial fibrosis (TIF) and using immunoperoxidase labeling, determined βig-h3 expression in renal tissues of patients with chronic CyAN. Urinary βig-h3 excretion was higher in chronic CyAN compared to control subjects (173.4 ± 26.0 vs 62.6 ± 5.0 ng/mg creatinine, P < .01). In chronic CyAN, the degree of TIF correlated with increased urinary βig-h3 levels (r = .785, P < .05). In kidneys with chronic CyAN, βig-h3 labeling was more prominent at the basement membranes (BM) of the tubules where inflammatory cells had infiltrated the surrounding interstitium. Moreover, the BM of the atrophied tubules and their surrounding interstitium were strongly labeled. Urinary βig-h3 levels decreased from 173.4 ± 26.0 to 64.9 ± 14.4 ng/mg creatinine at 1 month after discontinuation of CyA or reduction in CyA dosage (P < .01) despite unchanged serum creatinine levels. Urinary βig-h3 levels increased in patients with chronic CyAN and decreased after discontinuation or reduction of CyA dosage. Our results suggested that urinary βig-h3 levels could be used as a sensitive urinary marker to monitor the progression or regression of chronic CyAN.

UR - http://www.scopus.com/inward/record.url?scp=33745199359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745199359&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.02.070

DO - 10.1016/j.transproceed.2006.02.070

M3 - Article

C2 - 16797290

AN - SCOPUS:33745199359

VL - 38

SP - 1314

EP - 1319

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 5

ER -